Webinar on Omicron: New challenge in India

The new hyper-mutated Omicron variant of Covid–19 was first originated in South Africa in November and since then spreading very rapidly across the globe.

In India also, omicron statistics are steadily rising with fresh cases found in Maharashtra, Rajasthan and in Delhi as well. It is generally expected that new variant to be milder in people with a history of previous infection or vaccination. However, people with no form of protective immunity may experience similar patterns of disease severity as has been seen with earlier variants.

In our country, people have developed antibodies and more importantly the immunity over the time. However, people shouldn’t be "complacent” rather "need to be more alert and cautioned”.

According to the World Health Organisation (WHO), "preliminary data doesn't indicate that Omicron is more severe than its predecessor Delta”.

Amidst the potent challenges of new variant, there are ample studies depicting divergent views regarding the transmissibility & severity of disease, effectiveness of vaccination, additional or booster doses, as compared to other variants, including Delta.

In view of above, with the objectives to cascade awareness and disseminate wisdom about the more clarity on the symptoms, transmission & severity of disease, effectiveness of vaccination and additional or booster doses to protect against this potent and critical danger of new variant to lead a healthy life, under Illness To Wellness campaign, ASSOCHAM organized a webinar on “OMICRON: A New Challenge in India” scheduled on Thursday, 23rd December 2021 from 3.00 PM To 4.00 PM.

Eminent Speakers

Dr. Tarun Sahni, General Physician, Internal Medicine, Indraprastha Apollo Hospitals

Dr. Manoj K. Goel, Director & Head, Pulmonology Critical Care & Sleep Medicine, Fortis Memorial Research Institute Gurugram, Delhi (NCR)

Dr. Rajesh Kesari, Founder and Director Total Care Control, Delhi-NCR Shri Anil Rajput, Chairperson ASSOCHAM CSR Council